Ceribell (CBLL) Shares Outstanding (Weighted Average) (2023 - 2026)
Ceribell posted quarterly Shares Outstanding (Weighted Average) of $37.7 million for Q1 2026, up 4.97% year-on-year from $35.9 million in Q1 2025, and up 36716.59% on a QoQ basis from $102299.0 in Q4 2025.
Ceribell (CBLL) has 4 years of Shares Outstanding (Weighted Average) data on file, last reported at $37.7 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 4.97% year-over-year to $37.7 million; the trailing twelve-month figure through Mar 2026 stood at $37.7 million (up 4.97% YoY), and the FY2025 full-year result was $102299.0, down 99.14% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $37.7 million, up from $102299.0 in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $37.7 million in Q1 2026 and bottomed at $102299.0 in Q4 2025.
- The 4-year median for Shares Outstanding (Weighted Average) is $5.5 million (2024), against an average of $16.8 million.
- Peak annual rise in Shares Outstanding (Weighted Average) reached 557.48% in 2025, while the deepest fall reached 99.14% in 2025.
- A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $5.3 million in 2023, then surged by 125.31% to $11.9 million in 2024, then slumped by 99.14% to $102299.0 in 2025, then jumped by 36716.59% to $37.7 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $37.7 million (Q1 2026), $102299.0 (Q4 2025), and $36.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Ceribell | 666.26 Mn | 525.07 Mn | 23.12 Mn | 37.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.66 Mn |
| Dec 31, 2025 | 102,299.00 |
| Sep 30, 2025 | 36.33 Mn |
| Jun 30, 2025 | 36.09 Mn |
| Mar 31, 2025 | 35.88 Mn |
| Dec 31, 2024 | 11.95 Mn |
| Sep 30, 2024 | 5.55 Mn |
| Jun 30, 2024 | 5.51 Mn |
| Mar 31, 2024 | 5.46 Mn |
| Dec 31, 2023 | 5.30 Mn |
| Sep 30, 2023 | 5.34 Mn |